BackMedSmart Group Overview
MedSmart Group Inc.

MedSmart Group Return on Equity

Latest ROE for MedSmart Group: 36.43% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

36.43%

Return on Equity

36.43%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

MedSmart Group (MSGP) FAQ

MedSmart Group (MSGP) currently reports a ROE of 36.43%. That is above the sector sector average of 11.3%. Use the charts on this page to explore MedSmart Group's ROE history and peer comparisons.

MedSmart Group's ROE of 36.43% is higher than the its sector sector average of 11.3%. That is roughly 222.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but MedSmart Group's current 36.43% should be judged against industry norms (sector average: 11.3%) and against MSGP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 36.43%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.3%. From there, open related valuation or income-statement pages for MedSmart Group, and consider following MSGP for alerts when major investors trade the stock.